Metropolitan Life Insurance Company (MetLife)’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-7,987
Closed -$122K 2934
2021
Q1
$122K Sell
7,987
-987
-11% -$16K ﹤0.01% 2333
2020
Q4
$145K Hold
8,974
﹤0.01% 2153
2020
Q3
$125K Buy
8,974
+3,024
+51% +$45.1K ﹤0.01% 2087
2020
Q2
$127K Hold
5,950
﹤0.01% 2113
2020
Q1
$98.5K Buy
+5,950
New +$108K ﹤0.01% 2039

Other funds holding BCEL

Metropolitan Life Insurance Company (MetLife)'s BCEL Position: Q2 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q2 2021, closing a stake of 7,987 shares — an estimated $122K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in BCEL in Q1 2020 and held it in 5 quarters. The position peaked at $145K in Q4 2020. 108 funds tracked by Wall St. Rank hold BCEL as of Q2 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Atreca, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 7,987 Atreca, Inc. Class A Common Stock shares in Q2 2021, an estimated $122K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Atreca, Inc. Class A Common Stock in Q1 2020 and held it in 5 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Atreca, Inc. Class A Common Stock position peaked at $145K in Q4 2020.
  • 108 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q2 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.